Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

[1]  R. Lupu,et al.  Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas , 1999, Oncogene.

[2]  E. Radany,et al.  erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. , 1999, Endocrinology.

[3]  J. Swantek,et al.  Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor. , 1999, Endocrinology.

[4]  K. Horwitz,et al.  Convergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer , 1998, The Journal of Biological Chemistry.

[5]  K. Horwitz,et al.  Convergence of Progesterone with Growth Factor and Cytokine Signaling in Breast Cancer , 1998, The Journal of Biological Chemistry.

[6]  A. Molinolo,et al.  Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  Wen-rong Gong,et al.  Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen receptor , 1998, The EMBO journal.

[8]  D. Stern,et al.  Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  K. Horwitz,et al.  Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). , 1997, Molecular endocrinology.

[10]  N. Hynes,et al.  ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.

[11]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[12]  L. Pierce,et al.  Insulin‐like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c‐erbB‐2 gene amplification and progressively elevated levels of tyrosine‐phosphorylated p185erbB‐2 , 1996, Molecular carcinogenesis.

[13]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[14]  R. Lupu,et al.  Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells , 1995, International journal of cancer.

[15]  R. Dickson,et al.  Growth factors in breast cancer. , 1995, Endocrine reviews.

[16]  S. Ethier,et al.  Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin‐like growth factor‐I in human mammary epithelial cells , 1995, Journal of cellular physiology.

[17]  C T Roberts,et al.  Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.

[18]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[19]  L. Williams,et al.  An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. , 1994, Science.

[20]  E. Gelmann,et al.  erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification. , 1994, British Journal of Cancer.

[21]  A. Molinolo,et al.  Effect of sialoadenectomy on medroxyprogesterone‐acetate‐induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal‐growth‐factor receptor content , 1994, International journal of cancer.

[22]  C. Heldin,et al.  Activation of p70/p85 S6 kinase by a pathway independent of p21fi ras , 1994, Nature.

[23]  L. Cantley,et al.  A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling , 1994, Cell.

[24]  D. Coppola,et al.  A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor , 1994, Molecular and cellular biology.

[25]  D. Taverna,et al.  ErbB‐2 expression in estrogen‐receptor‐positive breast‐tumor cells is regulated by growth‐modulatory reagents , 1994, International journal of cancer.

[26]  M. Kraus,et al.  Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members , 1994, Molecular and cellular biology.

[27]  R. Weinberg,et al.  The pathway to signal achievement , 1993, Nature.

[28]  G. Plowman,et al.  Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[30]  T. Pawson,et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.

[31]  D. Goeddel,et al.  Identification of Heregulin, a Specific Activator of p185erbB2 , 1992, Science.

[32]  P. Nowell,et al.  Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line , 1991, Journal of cellular biochemistry.

[33]  G. Plowman,et al.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Katzenellenbogen,et al.  Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. , 1990, Cancer research.

[35]  C. Clarke,et al.  Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.

[36]  M. Kraus,et al.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Molinolo,et al.  Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and egf receptors of BALB/c In vivo sublines , 1989, International journal of cancer.

[38]  W. Blattner,et al.  Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor. , 1988, Cancer research.

[39]  L. Murphy,et al.  Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. , 1988, Cancer research.

[40]  L. Demers,et al.  Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway. , 1987, Cancer research.

[41]  S. Cowan,et al.  Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition. , 1987, European journal of cancer & clinical oncology.

[42]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[43]  L. Murphy,et al.  Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. , 1986, Cancer research.

[44]  N. Nomura,et al.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.

[45]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[46]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[47]  T. Hunter,et al.  Receptor protein-tyrosine kinases and their signal transduction pathways. , 1994, Annual review of cell biology.